Key regions: South Korea, Japan, Europe, Brazil, United Kingdom
The Other Pharmaceuticals market in Romania has been experiencing steady growth in recent years.
Customer preferences: Customers in Romania are increasingly seeking out alternative and natural remedies for their healthcare needs. This trend has led to a rise in demand for Other Pharmaceuticals, which includes homeopathic and traditional medicines. Additionally, the aging population in Romania has also contributed to the growth of this market segment, as older individuals tend to rely more on alternative medicines.
Trends in the market: The Other Pharmaceuticals market in Romania has been growing steadily due to the increased demand for alternative medicines. The market is expected to continue growing at a steady pace in the coming years. However, there has been some concern over the safety and efficacy of some of these alternative medicines. As a result, the Romanian government has implemented stricter regulations on these products to ensure their safety and quality.
Local special circumstances: Romania has a long history of traditional medicine, which has contributed to the popularity of alternative medicines. Additionally, the country has a large aging population, which has driven demand for healthcare products and services. However, the Romanian healthcare system has been struggling in recent years due to a lack of funding and resources. This has led to a rise in the popularity of alternative medicines, as people seek out more affordable healthcare options.
Underlying macroeconomic factors: The Romanian economy has been growing steadily in recent years, which has contributed to the growth of the Other Pharmaceuticals market. Additionally, the country's membership in the European Union has allowed for increased trade and investment in the healthcare sector. However, the Romanian healthcare system has been facing significant challenges, including a shortage of healthcare professionals and a lack of funding. These challenges may impact the growth of the Other Pharmaceuticals market in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
